Strategic Focus Target neurosurgical centers and hospitals adopting intra-operative imaging to expand bedside capabilities, aligning sales pitches with inTRAvent’s mission to improve safety and efficacy during neurosurgical procedures.

Clinical Leadership Leverage recent leadership appointments (Chief Clinical Strategy Officer and Chief Innovation Officer) to position partnerships around clinical strategy, product development, and adoption of SOLOPASS and related imaging/navigation solutions.

Regulatory Milestones Highlight FDA 510(k) clearance history for SOLOPASS as proof of regulatory credibility to accelerate discussions with larger medical device customers and potential distributors.

Growth Readiness With a focused product line and revenue under one million, pursue early adopters and pilot programs at smaller neurosurgery centers to demonstrate value and build a scalable reference base.

Ecosystem Fit Position collaboration opportunities with large medical device players and integrated care networks by emphasizing compatibility with existing intra-operative imaging workflows and navigation ecosystems.